8-100213070-C-T

Variant summary

Our verdict is Benign. The variant received -18 ACMG points: 0P and 18B. BP4_ModerateBP6_Very_StrongBA1

The NM_003114.5(SPAG1):​c.1097-20C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.351 in 1,439,426 control chromosomes in the GnomAD database, including 90,831 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.33 ( 8799 hom., cov: 33)
Exomes 𝑓: 0.35 ( 82032 hom. )

Consequence

SPAG1
NM_003114.5 intron

Scores

1
1

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 0.630

Publications

5 publications found
Variant links:
Genes affected
SPAG1 (HGNC:11212): (sperm associated antigen 1) The correlation of anti-sperm antibodies with cases of unexplained infertility implicates a role for these antibodies in blocking fertilization. Improved diagnosis and treatment of immunologic infertility, as well as identification of proteins for targeted contraception, are dependent on the identification and characterization of relevant sperm antigens. The protein expressed by this gene is recognized by anti-sperm agglutinating antibodies from an infertile woman. Furthermore, immunization of female rats with the recombinant human protein reduced fertility. This protein localizes to the plasma membrane of germ cells in the testis and to the post-acrosomal plasma membrane of mature spermatozoa. Recombinant polypeptide binds GTP and exhibits GTPase activity. Thus, this protein may regulate GTP signal transduction pathways involved in spermatogenesis and fertilization. Two transcript variants of this gene encode the same protein. [provided by RefSeq, Jul 2008]
SPAG1 Gene-Disease associations (from GenCC):
  • primary ciliary dyskinesia 28
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, PanelApp Australia, G2P
  • primary ciliary dyskinesia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -18 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.32).
BP6
Variant 8-100213070-C-T is Benign according to our data. Variant chr8-100213070-C-T is described in ClinVar as Benign. ClinVar VariationId is 262800.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.492 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SPAG1NM_003114.5 linkc.1097-20C>T intron_variant Intron 10 of 18 ENST00000388798.7 NP_003105.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SPAG1ENST00000388798.7 linkc.1097-20C>T intron_variant Intron 10 of 18 1 NM_003114.5 ENSP00000373450.3
SPAG1ENST00000251809.4 linkc.1097-20C>T intron_variant Intron 10 of 18 5 ENSP00000251809.3
SPAG1ENST00000523302.1 linkn.-17C>T upstream_gene_variant 3
ENSG00000302563ENST00000787874.1 linkn.-129G>A upstream_gene_variant

Frequencies

GnomAD3 genomes
AF:
0.330
AC:
49989
AN:
151520
Hom.:
8792
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.224
Gnomad AMI
AF:
0.350
Gnomad AMR
AF:
0.450
Gnomad ASJ
AF:
0.348
Gnomad EAS
AF:
0.508
Gnomad SAS
AF:
0.299
Gnomad FIN
AF:
0.325
Gnomad MID
AF:
0.338
Gnomad NFE
AF:
0.355
Gnomad OTH
AF:
0.331
GnomAD2 exomes
AF:
0.362
AC:
21352
AN:
59054
AF XY:
0.351
show subpopulations
Gnomad AFR exome
AF:
0.196
Gnomad AMR exome
AF:
0.509
Gnomad ASJ exome
AF:
0.341
Gnomad EAS exome
AF:
0.432
Gnomad FIN exome
AF:
0.343
Gnomad NFE exome
AF:
0.354
Gnomad OTH exome
AF:
0.371
GnomAD4 exome
AF:
0.354
AC:
455477
AN:
1287800
Hom.:
82032
Cov.:
30
AF XY:
0.352
AC XY:
223715
AN XY:
635522
show subpopulations
African (AFR)
AF:
0.213
AC:
5369
AN:
25172
American (AMR)
AF:
0.479
AC:
9328
AN:
19470
Ashkenazi Jewish (ASJ)
AF:
0.338
AC:
7405
AN:
21904
East Asian (EAS)
AF:
0.492
AC:
13515
AN:
27494
South Asian (SAS)
AF:
0.295
AC:
20671
AN:
69972
European-Finnish (FIN)
AF:
0.321
AC:
10105
AN:
31482
Middle Eastern (MID)
AF:
0.315
AC:
1609
AN:
5114
European-Non Finnish (NFE)
AF:
0.357
AC:
369065
AN:
1034498
Other (OTH)
AF:
0.349
AC:
18410
AN:
52694
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
14314
28628
42942
57256
71570
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
12276
24552
36828
49104
61380
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.330
AC:
50011
AN:
151626
Hom.:
8799
Cov.:
33
AF XY:
0.332
AC XY:
24571
AN XY:
74120
show subpopulations
African (AFR)
AF:
0.224
AC:
9217
AN:
41088
American (AMR)
AF:
0.450
AC:
6885
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.348
AC:
1207
AN:
3470
East Asian (EAS)
AF:
0.508
AC:
2625
AN:
5164
South Asian (SAS)
AF:
0.300
AC:
1448
AN:
4822
European-Finnish (FIN)
AF:
0.325
AC:
3430
AN:
10554
Middle Eastern (MID)
AF:
0.332
AC:
97
AN:
292
European-Non Finnish (NFE)
AF:
0.355
AC:
24085
AN:
67930
Other (OTH)
AF:
0.331
AC:
699
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
1713
3427
5140
6854
8567
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
496
992
1488
1984
2480
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.312
Hom.:
944
Bravo
AF:
0.336
Asia WGS
AF:
0.385
AC:
1332
AN:
3456

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Dec 17, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Primary ciliary dyskinesia 28 Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.32
CADD
Benign
19
DANN
Uncertain
0.98
PhyloP100
0.63
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3098659; hg19: chr8-101225298; COSMIC: COSV52562792; COSMIC: COSV52562792; API